arrow
H

Hyon-Xhi Tan

University of Melbourne
H指数:30
被引数:3,473

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses

历史性的1994年流感疫苗队列定义了针对未来甲型和乙型流感病毒的抗体和B细胞反应的广度

2026-04-010
PRE
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responses

一种新型嵌合冠状病毒刺突疫苗,结合了SARS-CoV-2 RBD和来自HKU-1的支架结构域,能够诱导强烈的中和抗体反应

2025-11-280
OAAI
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies

结构趋同和水介导的底物模拟使人类抗体能够广泛抑制神经氨酸酶

2025-08-010
OAAI
Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens

双价mRNA加强疫苗接种可重新激活针对抗原性分化的SARS-CoV-2刺突抗原的细胞免疫和抗体免疫。

2025-04-180
OA
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines
2025-01-090
OA
SARS- CoV-2-specific CD8+T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years

来自长COVID患者的传染性非典型肺炎CoV-2-specific CD8 T细胞建立并维持效应子表型和关键TCR特征超过2年

2024-09-160
OAAI
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection

SARS-CoV-2感染后24个月长COVID个体免疫失调的改善

2024-04-176
OAAI
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19

从新型冠状病毒肺炎中恢复的住院第一民族的广谱SARS-CoV-2-specific免疫力

2023-09-191
OAAI
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection

Omicron突破性感染后中和抗体反应的持久重编程

2023-07-2111
OAAI
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities
2023-05-2913
OAAI
Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and ?? T cell perturbations

怀孕期间SARS-CoV-2感染的免疫分析揭示了NK细胞和??T细胞扰动

2023-04-1010
OA
Robust SARS-CoV-2 T cell responses with common TCRab motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells
2023-04-0113
OAAI
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
IMMUNITY
IF26.3
2023-04-0159
OAAI